3rd Quarter - Report

GILEAD SCIENCES, INC. for GILEAD SCIENCES INC

Firm
Client
Income
—
Expenses
$1,480,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

7 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

Issues related to pharmaceuticals and intellectual property protection including technology transfer, patent rights and funding.

LobbyistCovered position, as disclosed
CHARLES M. CLAPTON —
DAVID PULLIAM —

Contacted: U.S. Trade Representative (USTR); State, Dept of (DOS); Commerce, Dept of (DOC); Centers For Medicare and Medicaid Services (CMS); SENATE; Treasury, Dept of; HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS)

Taxation/Internal Revenue Code TAX

Implementation of the Tax Cuts and Jobs Act of 2017 (P.L. 115-97)

LobbyistCovered position, as disclosed
CHARLES M. CLAPTON —
DAVID PULLIAM —

Contacted: Office of Management & Budget (OMB); Commerce, Dept of (DOC); Centers For Medicare and Medicaid Services (CMS); Centers For Disease Control & Prevention (CDC); U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); Treasury, Dept of; State, Dept of (DOS); HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Expanding access to HIV treatment and prevention therapies including, Administration proposals; Ryan White Care Act reauthorization; PEPFAR reauthorization; HIV/AIDS access to care, research, testing and treatment. HCV screening and linkage to care programs; coverage and reimbursement policy for HCV, HIV and oncology portfolio. Pharmaceutical policy as it relates to payments under the 340B program. S.1416 - Affordable Prescriptions for Patients Act of 2019 S.1895 - Lower Health Care Costs Act H.R.3 - Lower Drug Costs Now Act S.2543 - Prescription Drug Pricing Reduction Act H.R.1643 - PrEP Assistance Program Act S.1926 - The PrEP Access and Coverage Act

LobbyistCovered position, as disclosed
MICHAEL D BOYD —
CHARLES M. CLAPTON —
COOKAB HASHEMI —
DAVID PULLIAM —

Contacted: Commerce, Dept of (DOC); Office of Management & Budget (OMB); SENATE; State, Dept of (DOS); U.S. Trade Representative (USTR); Centers For Medicare and Medicaid Services (CMS); Centers For Disease Control & Prevention (CDC); Treasury, Dept of; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 1643 (116th), S. 1926 (116th), H.R. 3 (116th), S. 1895 (116th), S. 2543 (116th), S. 1416 (116th)

Medicare/Medicaid MMM

Administration drug pricing proposals. HCV testing, screening and linkage to care programs. Medicaid and Medicare coverage, access and reimbursement issues for Hepatitis C, HIV, and oncology products, including the New Technology Add-On Payment program. Part D benefit redesign. Administration regulations including: "Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of Pocket Spending"; "Medicare Program; Hospital Inpatient Prospective Payment Systems for Fiscal Year 2020 Rates; Proposed Quality Reporting Requirements for Specific Providers; Medicare and Medicaid Promoting Interoperability Programs Proposed Requirements for Eligible Hospitals and Critical Access Hospitals" (84 FR 19158, 42 CFR 412). S.2543 - The Prescription Drug Pricing Reduction Act H.R.3 - The Lower Drug Costs Now Act H.R.259 - Medicaid Extenders Act of 2019

LobbyistCovered position, as disclosed
MICHAEL D BOYD —
CHARLES M. CLAPTON —
COOKAB HASHEMI —
DAVID PULLIAM —

Contacted: U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); State, Dept of (DOS); Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS); SENATE; Treasury, Dept of; Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB)

Bills named: H.R. 259 (116th), H.R. 3 (116th), S. 2543 (116th)

Budget/Appropriations BUD

Administration drug pricing proposals. Funding for HCV, HIV and public health activities via appropriations. H.R.2740 - HHS Appropriations, 2020 H.R.3164 - FDA Appropriations, 2020 H.R.2839 - Department of State, Foreign Operations, and Related Programs Appropriations Act, 2020 H.R.4378 - Continuing Appropriations Act and Health Extenders Act

LobbyistCovered position, as disclosed
CHARLES M. CLAPTON —
COOKAB HASHEMI —
DAVID PULLIAM —

Contacted: Treasury, Dept of; SENATE; HOUSE OF REPRESENTATIVES; State, Dept of (DOS); U.S. Trade Representative (USTR); Commerce, Dept of (DOC); Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 4378 (116th), H.R. 2740 (116th), H.R. 2839 (116th), H.R. 3164 (116th)

Trade (domestic/foreign) TRD

International trade and protection of intellectual property; compulsory licensing and other IP issues in multiple countries.

LobbyistCovered position, as disclosed
CHARLES M. CLAPTON —
DAVID PULLIAM —

Contacted: Centers For Disease Control & Prevention (CDC); U.S. Trade Representative (USTR); Centers For Medicare and Medicaid Services (CMS); Commerce, Dept of (DOC); SENATE; Treasury, Dept of; HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); State, Dept of (DOS); Health & Human Services, Dept of (HHS)

Veterans VET

Education related to hepatitis C and HIV.

LobbyistCovered position, as disclosed
CHARLES M. CLAPTON —
COOKAB HASHEMI —
DAVID PULLIAM —

Contacted: Centers For Medicare and Medicaid Services (CMS); Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Centers For Disease Control & Prevention (CDC); State, Dept of (DOS); SENATE; Treasury, Dept of; Commerce, Dept of (DOC); U.S. Trade Representative (USTR)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.